Drug Screen, G0431 – OR, WA Widespread Service Specific Probe Review Notification

Noridian Part B Medical Review has analyzed national and local data in conjunction with the findings from Comprehensive Error Rate Testing (CERT) to identify atypical billing; therefore, a service specific probe review is being initiated for Oregon and Washington who have submitted HCPCS ® G0431 – Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter. Noridian MR will review documentation submitted to support claims suspended during this review and post findings on the website.

Source: https://med.noridianmedicare.com/web/jfb/article-detail/-/view/10534/drug-screen-g0431-or-wa-widespread-service-specific-probe-review-notificati-1